カテゴリー： LP Information, 世界, 医療/バイオ

世界の皮膚科処方薬市場予測 2021年-2026年

【英語タイトル】Global Prescription Dermatological Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9553）・商品コード：LPI21MY9553
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：138
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「皮膚科処方薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、抗ニキビ治療薬、老化防止治療薬、皮膚炎治療薬、脱毛治療薬、乾癬治療薬、皮膚がん治療薬、肝斑治療薬、脂漏症治療薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。皮膚科処方薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・皮膚科処方薬の世界市場概要（サマリー）
・皮膚科処方薬の企業別販売量・売上
・皮膚科処方薬の企業別市場シェア
・皮膚科処方薬の世界市場規模 2016年-2021年：種類別（抗ニキビ治療薬、老化防止治療薬、皮膚炎治療薬、脱毛治療薬、乾癬治療薬、皮膚がん治療薬、肝斑治療薬、脂漏症治療薬）
・皮膚科処方薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局）
・皮膚科処方薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・皮膚科処方薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・皮膚科処方薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・皮膚科処方薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・皮膚科処方薬市場の成長要因・課題・動向
・皮膚科処方薬の世界市場予測 2021年-2026年
・皮膚科処方薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・皮膚科処方薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・皮膚科処方薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・皮膚科処方薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・皮膚科処方薬の世界市場予測：種類別（抗ニキビ治療薬、老化防止治療薬、皮膚炎治療薬、脱毛治療薬、乾癬治療薬、皮膚がん治療薬、肝斑治療薬、脂漏症治療薬）
・皮膚科処方薬の世界市場予測：用途別（病院薬局、小売薬局、オンライン薬局）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Prescription Dermatological Drugs will have significant change from previous year. By the most conservative estimates of global Prescription Dermatological Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Prescription Dermatological Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Dermatological Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prescription Dermatological Drugs Consumption 2016-2026
2.1.2 Prescription Dermatological Drugs Consumption CAGR by Region
2.2 Prescription Dermatological Drugs Segment by Type
2.2.1 Anti-acne Drugs
2.2.2 Anti-aging Drugs
2.2.3 Dermatitis Drugs
2.2.4 Hair Loss Drugs
2.2.5 Psoriasis Drugs
2.2.6 Skin Cancer Drugs
2.2.7 Melasma Drugs
2.2.8 Seborrhea Drugs
2.3 Prescription Dermatological Drugs Sales by Type
2.3.1 Global Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Prescription Dermatological Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Prescription Dermatological Drugs Sale Price by Type (2016-2021)
2.4 Prescription Dermatological Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Prescription Dermatological Drugs Sales by Application
2.5.1 Global Prescription Dermatological Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Prescription Dermatological Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Prescription Dermatological Drugs Sale Price by Application (2016-2021)

3 Global Prescription Dermatological Drugs by Company
3.1 Global Prescription Dermatological Drugs Sales Market Share by Company
3.1.1 Global Prescription Dermatological Drugs Sales by Company (2019-2021)
3.1.2 Global Prescription Dermatological Drugs Sales Market Share by Company (2019-2021)
3.2 Global Prescription Dermatological Drugs Revenue Market Share by Company
3.2.1 Global Prescription Dermatological Drugs Revenue by Company (2019-2021)
3.2.2 Global Prescription Dermatological Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Prescription Dermatological Drugs Sale Price by Company
3.4 Global Manufacturers Prescription Dermatological Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prescription Dermatological Drugs Product Location Distribution
3.4.2 Players Prescription Dermatological Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Prescription Dermatological Drugs by Region
4.1 Global Prescription Dermatological Drugs by Region
4.1.1 Global Prescription Dermatological Drugs Sales by Region
4.1.2 Global Prescription Dermatological Drugs Revenue by Region
4.2 Americas Prescription Dermatological Drugs Sales Growth
4.3 APAC Prescription Dermatological Drugs Sales Growth
4.4 Europe Prescription Dermatological Drugs Sales Growth
4.5 Middle East & Africa Prescription Dermatological Drugs Sales Growth

5 Americas
5.1 Americas Prescription Dermatological Drugs Sales by Country
5.1.1 Americas Prescription Dermatological Drugs Sales by Country (2016-2021)
5.1.2 Americas Prescription Dermatological Drugs Revenue by Country (2016-2021)
5.2 Americas Prescription Dermatological Drugs Sales by Type
5.3 Americas Prescription Dermatological Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Prescription Dermatological Drugs Sales by Region
6.1.1 APAC Prescription Dermatological Drugs Sales by Region (2016-2021)
6.1.2 APAC Prescription Dermatological Drugs Revenue by Region (2016-2021)
6.2 APAC Prescription Dermatological Drugs Sales by Type
6.3 APAC Prescription Dermatological Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Prescription Dermatological Drugs by Country
7.1.1 Europe Prescription Dermatological Drugs Sales by Country (2016-2021)
7.1.2 Europe Prescription Dermatological Drugs Revenue by Country (2016-2021)
7.2 Europe Prescription Dermatological Drugs Sales by Type
7.3 Europe Prescription Dermatological Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Prescription Dermatological Drugs by Country
8.1.1 Middle East & Africa Prescription Dermatological Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Prescription Dermatological Drugs Sales by Type
8.3 Middle East & Africa Prescription Dermatological Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Prescription Dermatological Drugs Distributors
10.3 Prescription Dermatological Drugs Customer

11 Global Prescription Dermatological Drugs Market Forecast
11.1 Global Prescription Dermatological Drugs Forecast by Region
11.1.1 Global Prescription Dermatological Drugs Forecast by Regions (2021-2026)
11.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Prescription Dermatological Drugs Forecast by Type
11.7 Global Prescription Dermatological Drugs Forecast by Application

12 Key Players Analysis
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Johnson & Johnson Company Information
12.1.2 Johnson & Johnson Prescription Dermatological Drugs Product Offered
12.1.3 Johnson & Johnson Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson & Johnson Main Business Overview
12.1.5 Johnson & Johnson Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Prescription Dermatological Drugs Product Offered
12.2.3 Merck Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 Bayer
12.3.1 Bayer Company Information
12.3.2 Bayer Prescription Dermatological Drugs Product Offered
12.3.3 Bayer Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Bayer Main Business Overview
12.3.5 Bayer Latest Developments
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Company Information
12.4.2 Mylan Pharmaceuticals Prescription Dermatological Drugs Product Offered
12.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Pharmaceuticals Main Business Overview
12.4.5 Mylan Pharmaceuticals Latest Developments
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Prescription Dermatological Drugs Product Offered
12.5.3 Pfizer Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Pfizer Main Business Overview
12.5.5 Pfizer Latest Developments
12.6 F. Hoffmann-La Roche
12.6.1 F. Hoffmann-La Roche Company Information
12.6.2 F. Hoffmann-La Roche Prescription Dermatological Drugs Product Offered
12.6.3 F. Hoffmann-La Roche Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 F. Hoffmann-La Roche Main Business Overview
12.6.5 F. Hoffmann-La Roche Latest Developments
12.7 Allergan
12.7.1 Allergan Company Information
12.7.2 Allergan Prescription Dermatological Drugs Product Offered
12.7.3 Allergan Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Allergan Main Business Overview
12.7.5 Allergan Latest Developments
12.8 Bausch Health
12.8.1 Bausch Health Company Information
12.8.2 Bausch Health Prescription Dermatological Drugs Product Offered
12.8.3 Bausch Health Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Bausch Health Main Business Overview
12.8.5 Bausch Health Latest Developments
12.9 PharmaDerm Pharmaceuticals
12.9.1 PharmaDerm Pharmaceuticals Company Information
12.9.2 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Offered
12.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 PharmaDerm Pharmaceuticals Main Business Overview
12.9.5 PharmaDerm Pharmaceuticals Latest Developments
12.10 Allergan Inamed Corporation
12.10.1 Allergan Inamed Corporation Company Information
12.10.2 Allergan Inamed Corporation Prescription Dermatological Drugs Product Offered
12.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Allergan Inamed Corporation Main Business Overview
12.10.5 Allergan Inamed Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Prescription Dermatological Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Anti-acne Drugs
Table 3. Major Players of Anti-aging Drugs
Table 4. Major Players of Dermatitis Drugs
Table 5. Major Players of Hair Loss Drugs
Table 6. Major Players of Psoriasis Drugs
Table 7. Major Players of Skin Cancer Drugs
Table 8. Major Players of Melasma Drugs
Table 9. Major Players of Seborrhea Drugs
Table 10. Global Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 11. Global Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 12. Global Prescription Dermatological Drugs Revenue by Type (2016-2021) & ($ million)
Table 13. Global Prescription Dermatological Drugs Revenue Market Share by Type (2016-2021)
Table 14. Global Prescription Dermatological Drugs Sale Price by Type (2016-2021)
Table 15. Global Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 16. Global Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 17. Global Prescription Dermatological Drugs Value by Application (2016-2021)
Table 18. Global Prescription Dermatological Drugs Revenue Market Share by Application (2016-2021)
Table 19. Global Prescription Dermatological Drugs Sale Price by Application (2016-2021)
Table 20. Global Prescription Dermatological Drugs Sales by Company (2019-2021) & (K Units)
Table 21. Global Prescription Dermatological Drugs Sales Market Share by Company (2019-2021)
Table 22. Global Prescription Dermatological Drugs Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Prescription Dermatological Drugs Revenue Market Share by Company (2019-2021)
Table 24. Global Prescription Dermatological Drugs Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Prescription Dermatological Drugs Producing Area Distribution and Sales Area
Table 26. Players Prescription Dermatological Drugs Products Offered
Table 27. Prescription Dermatological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Prescription Dermatological Drugs Sales by Region (2016-2021) (K Units)
Table 31. Global Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
Table 32. Global Prescription Dermatological Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Prescription Dermatological Drugs Revenue Market Share by Region (2016-2021)
Table 34. Americas Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Americas Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 36. Americas Prescription Dermatological Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 38. Americas Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 39. Americas Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 40. Americas Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 41. Americas Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 42. APAC Prescription Dermatological Drugs Sales by Region (2016-2021) & (K Units)
Table 43. APAC Prescription Dermatological Drugs Sales Market Share by Region (2016-2021)
Table 44. APAC Prescription Dermatological Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Prescription Dermatological Drugs Revenue Market Share by Region (2016-2021)
Table 46. APAC Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 47. APAC Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 48. APAC Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 49. APAC Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 50. Europe Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 51. Europe Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 52. Europe Prescription Dermatological Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 54. Europe Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 57. Europe Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Prescription Dermatological Drugs Sales by Country (2016-2021) & (K Units)
Table 59. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Prescription Dermatological Drugs Sales by Type (2016-2021) & (K Units)
Table 63. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Prescription Dermatological Drugs Sales by Application (2016-2021) & (K Units)
Table 65. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Table 66. Global Prescription Dermatological Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 67. Global Prescription Dermatological Drugs Sales Market Share Forecast by Type (2021-2026)
Table 68. Global Prescription Dermatological Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 69. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 70. Global Prescription Dermatological Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 71. Global Prescription Dermatological Drugs Sales Market Share Forecast by Application (2021-2026)
Table 72. Global Prescription Dermatological Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 73. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 74. Johnson & Johnson Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Johnson & Johnson Prescription Dermatological Drugs Product Offered
Table 76. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. Merck Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Prescription Dermatological Drugs Product Offered
Table 81. Merck Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Bayer Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer Prescription Dermatological Drugs Product Offered
Table 86. Bayer Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 87. Bayer Main Business
Table 88. Bayer Latest Developments
Table 89. Mylan Pharmaceuticals Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Pharmaceuticals Prescription Dermatological Drugs Product Offered
Table 91. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 92. Mylan Pharmaceuticals Main Business
Table 93. Mylan Pharmaceuticals Latest Developments
Table 94. Pfizer Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Prescription Dermatological Drugs Product Offered
Table 96. Pfizer Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. F. Hoffmann-La Roche Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Prescription Dermatological Drugs Product Offered
Table 101. F. Hoffmann-La Roche Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 102. F. Hoffmann-La Roche Main Business
Table 103. F. Hoffmann-La Roche Latest Developments
Table 104. Allergan Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Allergan Prescription Dermatological Drugs Product Offered
Table 106. Allergan Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 107. Allergan Main Business
Table 108. Allergan Latest Developments
Table 109. Bausch Health Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Bausch Health Prescription Dermatological Drugs Product Offered
Table 111. Bausch Health Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 112. Bausch Health Main Business
Table 113. Bausch Health Latest Developments
Table 114. PharmaDerm Pharmaceuticals Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product Offered
Table 116. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 117. PharmaDerm Pharmaceuticals Main Business
Table 118. PharmaDerm Pharmaceuticals Latest Developments
Table 119. Allergan Inamed Corporation Basic Information, Prescription Dermatological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Allergan Inamed Corporation Prescription Dermatological Drugs Product Offered
Table 121. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Revenue ($ Million), Price (USD/Units) and Gross Margin (2019-2021E)
Table 122. Allergan Inamed Corporation Main Business
Table 123. Allergan Inamed Corporation Latest Developments
List of Figures
Figure 1. Picture of Prescription Dermatological Drugs
Figure 2. Prescription Dermatological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prescription Dermatological Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Prescription Dermatological Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Prescription Dermatological Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Anti-acne Drugs
Figure 10. Product Picture of Anti-aging Drugs
Figure 11. Product Picture of Dermatitis Drugs
Figure 12. Product Picture of Hair Loss Drugs
Figure 13. Product Picture of Psoriasis Drugs
Figure 14. Product Picture of Skin Cancer Drugs
Figure 15. Product Picture of Melasma Drugs
Figure 16. Product Picture of Seborrhea Drugs
Figure 17. Global Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 18. Global Prescription Dermatological Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Prescription Dermatological Drugs Consumed in Hospital Pharmacies
Figure 20. Global Prescription Dermatological Drugs Market: Hospital Pharmacies (2016-2021) & (K Units)
Figure 21. Prescription Dermatological Drugs Consumed in Retail Pharmacies
Figure 22. Global Prescription Dermatological Drugs Market: Retail Pharmacies (2016-2021) & (K Units)
Figure 23. Prescription Dermatological Drugs Consumed in Online Pharmacies
Figure 24. Global Prescription Dermatological Drugs Market: Online Pharmacies (2016-2021) & (K Units)
Figure 25. Global Prescription Dermatological Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Prescription Dermatological Drugs Revenue Market Share by Application in 2020
Figure 27. Global Prescription Dermatological Drugs Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Prescription Dermatological Drugs Revenue Market Share by Company in 2020
Figure 29. Global Prescription Dermatological Drugs Sales Market Share by Regions (2016-2021)
Figure 30. Global Prescription Dermatological Drugs Revenue Market Share by Region in 2020
Figure 31. Americas Prescription Dermatological Drugs Sales 2016-2021 (K Units)
Figure 32. Americas Prescription Dermatological Drugs Revenue 2016-2021 ($ Millions)
Figure 33. APAC Prescription Dermatological Drugs Sales 2016-2021 (K Units)
Figure 34. APAC Prescription Dermatological Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Europe Prescription Dermatological Drugs Sales 2016-2021 (K Units)
Figure 36. Europe Prescription Dermatological Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Prescription Dermatological Drugs Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Prescription Dermatological Drugs Revenue 2016-2021 ($ Millions)
Figure 39. Americas Prescription Dermatological Drugs Sales Market Share by Country in 2020
Figure 40. Americas Prescription Dermatological Drugs Revenue Market Share by Country in 2020
Figure 41. Americas Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 42. Americas Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 43. United States Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Prescription Dermatological Drugs Sales Market Share by Region in 2020
Figure 48. APAC Prescription Dermatological Drugs Revenue Market Share by Regions in 2020
Figure 49. APAC Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 50. APAC Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 51. China Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2020
Figure 58. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2020
Figure 59. Europe Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 60. Europe Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 61. Germany Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 70. Egypt Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Prescription Dermatological Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles


★調査レポート[世界の皮膚科処方薬市場予測 2021年-2026年] (コード：LPI21MY9553)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の皮膚科処方薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の皮膚科用医薬品市場予測 2021年-2026年
    LPI21MY9505 / LP Information / 2021年5月 / LPインフォメーション社の「皮膚科用医薬品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、処方薬、市販薬など、用途別には、にきび、皮膚感染症、乾癬、皮膚炎治療薬、その他などにセグメント区分してまとめました。皮膚科用医薬品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・皮膚科用医薬品の世界市場概要（サマリー） ・皮膚科用医薬品の企業別販売量・売上 ・皮膚科用医薬品の企業別市場シェア ・皮膚科用医薬品の世界市場規模 2016年-2021年：種類別（処方薬、市販薬） ・皮膚科用医薬品の世界市場規模 2016年-2021年：用途別（にきび、皮膚感染症、乾癬、皮膚炎治療薬、その他） ・皮膚科用医薬品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・皮膚科用医薬品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Dermatological Drugs will have significant change from previous year. By the most conservative estimates of global Dermatological Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 23840 million in 2019. Over the next five years the Dermatological Drugs market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 28840 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Dermatological Drugs market by product type, application, key manufacturers and...
  • 世界の高脂血症処方薬市場予測 2021年-2026年
    LPI21MY9642 / LP Information / 2021年5月 / LPインフォメーション社の「高脂血症処方薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、HMG COAレダクターゼ阻害剤、ibフィブリン酸誘導体、ニコチン酸、胆汁酸封鎖剤、コレステロール吸収阻害剤、併用薬物療法など、用途別には、病院、クリニックなどにセグメント区分してまとめました。高脂血症処方薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高脂血症処方薬の世界市場概要（サマリー） ・高脂血症処方薬の企業別販売量・売上 ・高脂血症処方薬の企業別市場シェア ・高脂血症処方薬の世界市場規模 2016年-2021年：種類別（HMG COAレダクターゼ阻害剤、ibフィブリン酸誘導体、ニコチン酸、胆汁酸封鎖剤、コレステロール吸収阻害剤、併用薬物療法） ・高脂血症処方薬の世界市場規模 2016年-2021年：用途別（病院、クリニック）...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Hyperlipidemia Prescription Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Hyperlipidemia Prescription Drugs market by product type,...
  • 世界の双極性障害治療薬市場予測 2021年-2026年
    LPI21MY9449 / LP Information / 2021年5月 / LPインフォメーション社の「双極性障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、気分安定薬、抗精神病薬、抗うつ薬、その他薬品など、用途別には、病院、研究室、その他などにセグメント区分してまとめました。双極性障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・双極性障害治療薬の世界市場概要（サマリー） ・双極性障害治療薬の企業別販売量・売上 ・双極性障害治療薬の企業別市場シェア ・双極性障害治療薬の世界市場規模 2016年-2021年：種類別（気分安定薬、抗精神病薬、抗うつ薬、その他薬品） ・双極性障害治療薬の世界市場規模 2016年-2021年：用途別（病院、研究室、その他） ・双極性障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・双極性障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Bipolar Disorder Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorder Drugs market by product type,...
  • 世界の抗ニキビ薬市場予測 2021年-2026年
    LPI21MY9407 / LP Information / 2021年5月 / LPインフォメーション社の「抗ニキビ薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、アキュテイン、デスカム-E、クレオシンT、ベンザマイシン、エリスロマイシン局所、レチン-A、ミノサイクリンなど、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。抗ニキビ薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗ニキビ薬の世界市場概要（サマリー） ・抗ニキビ薬の企業別販売量・売上 ・抗ニキビ薬の企業別市場シェア ・抗ニキビ薬の世界市場規模 2016年-2021年：種類別（アキュテイン、デスカム-E、クレオシンT、ベンザマイシン、エリスロマイシン局所、レチン-A、ミノサイクリン） ・抗ニキビ薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・抗ニキビ薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗ニキビ薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Acne Drugs will have significant change from previous year. By the most conservative estimates of global Anti Acne Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Acne Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Acne Drugs market by product type,...
  • 世界の抗片頭痛薬市場予測 2021年-2026年
    LPI21MY9422 / LP Information / 2021年5月 / LPインフォメーション社の「抗片頭痛薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、トリプタン、麦角、その他など、用途別には、女性、男性などにセグメント区分してまとめました。抗片頭痛薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗片頭痛薬の世界市場概要（サマリー） ・抗片頭痛薬の企業別販売量・売上 ・抗片頭痛薬の企業別市場シェア ・抗片頭痛薬の世界市場規模 2016年-2021年：種類別（トリプタン、麦角、その他） ・抗片頭痛薬の世界市場規模 2016年-2021年：用途別（女性、男性） ・抗片頭痛薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗片頭痛薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti-Migraine Drugs will have significant change from previous year. By the most conservative estimates of global Anti-Migraine Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti-Migraine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Migraine Drugs market by product type, application, key manufacturers and...
  • 世界の免疫抑制薬市場予測 2021年-2026年
    LPI21MY9646 / LP Information / 2021年5月 / LPインフォメーション社の「免疫抑制薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体など、用途別には、腎臓、骨髄、その他などにセグメント区分してまとめました。免疫抑制薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・免疫抑制薬の世界市場概要（サマリー） ・免疫抑制薬の企業別販売量・売上 ・免疫抑制薬の企業別市場シェア ・免疫抑制薬の世界市場規模 2016年-2021年：種類別（カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体） ・免疫抑制薬の世界市場規模 2016年-2021年：用途別（腎臓、骨髄、その他） ・免疫抑制薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・免疫抑制薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Immunosuppressant Drugs will have significant change from previous year. By the most conservative estimates of global Immunosuppressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Immunosuppressant Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Immunosuppressant Drugs market by product type, application, key manufacturers and...
  • 世界の子宮頸がん治療薬市場予測 2021年-2026年
    LPI21MY9477 / LP Information / 2021年5月 / LPインフォメーション社の「子宮頸がん治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、前癌病変、初期浸潤段階、進行浸潤段階など、用途別には、病院、緩和ケアクリニック、診断センター、薬局などにセグメント区分してまとめました。子宮頸がん治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・子宮頸がん治療薬の世界市場概要（サマリー） ・子宮頸がん治療薬の企業別販売量・売上 ・子宮頸がん治療薬の企業別市場シェア ・子宮頸がん治療薬の世界市場規模 2016年-2021年：種類別（前癌病変、初期浸潤段階、進行浸潤段階） ・子宮頸がん治療薬の世界市場規模 2016年-2021年：用途別（病院、緩和ケアクリニック、診断センター、薬局） ・子宮頸がん治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・子宮頸がん治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cervical Cancer Drugs will have significant change from previous year. By the most conservative estimates of global Cervical Cancer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 12890 million in 2019. Over the next five years the Cervical Cancer Drugs market will register a 2.4% CAGR in terms of revenue, the global market size will reach US$ 14140 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cervical Cancer Drugs market by product type,...
  • 世界の処方用プロトンポンプ阻害剤市場予測 2021年-2026年
    LPI21MY9554 / LP Information / 2021年5月 / LPインフォメーション社の「処方用プロトンポンプ阻害剤の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ランソプラゾール、パントプラゾール、ラベプラゾール、その他など、用途別には、病院、研究所、その他などにセグメント区分してまとめました。処方用プロトンポンプ阻害剤のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・処方用プロトンポンプ阻害剤の世界市場概要（サマリー） ・処方用プロトンポンプ阻害剤の企業別販売量・売上 ・処方用プロトンポンプ阻害剤の企業別市場シェア ・処方用プロトンポンプ阻害剤の世界市場規模 2016年-2021年：種類別（ランソプラゾール、パントプラゾール、ラベプラゾール、その他） ・処方用プロトンポンプ阻害剤の世界市場規模 2016年-2021年：用途別（病院、研究所、その他） ・処方用プロトンポンプ阻害剤の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・処方用プロトンポンプ阻害剤のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Prescription Proton Pump Inhibitor will have significant change from previous year. By the most conservative estimates of global Prescription Proton Pump Inhibitor market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Prescription Proton Pump Inhibitor market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Proton Pump Inhibitor...
  • 世界の鎮咳薬市場予測 2021年-2026年
    LPI21MY9425 / LP Information / 2021年5月 / LPインフォメーション社の「鎮咳薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、中枢作用性鎮咳薬、局所作用性鎮咳薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。鎮咳薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・鎮咳薬の世界市場概要（サマリー） ・鎮咳薬の企業別販売量・売上 ・鎮咳薬の企業別市場シェア ・鎮咳薬の世界市場規模 2016年-2021年：種類別（中枢作用性鎮咳薬、局所作用性鎮咳薬） ・鎮咳薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・鎮咳薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・鎮咳薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antitussive Drugs will have significant change from previous year. By the most conservative estimates of global Antitussive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antitussive Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antitussive Drugs market by product type, application, key manufacturers and...
  • 世界の止瀉薬市場予測 2021年-2026年
    LPI21MY9409 / LP Information / 2021年5月 / LPインフォメーション社の「止瀉薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、処方薬、OTC薬など、用途別には、子供、成人などにセグメント区分してまとめました。止瀉薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・止瀉薬の世界市場概要（サマリー） ・止瀉薬の企業別販売量・売上 ・止瀉薬の企業別市場シェア ・止瀉薬の世界市場規模 2016年-2021年：種類別（処方薬、OTC薬） ・止瀉薬の世界市場規模 2016年-2021年：用途別（子供、成人） ・止瀉薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・止瀉薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Anti Diarrheal Drugs will have significant change from previous year. By the most conservative estimates of global Anti Diarrheal Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Diarrheal Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Anti Diarrheal Drugs market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆